MX358040B - Combinación de cría de zánganos y calcio para usarse en el tratamiento de cavidades en secciones metafiseanas (trabeculares). - Google Patents

Combinación de cría de zánganos y calcio para usarse en el tratamiento de cavidades en secciones metafiseanas (trabeculares).

Info

Publication number
MX358040B
MX358040B MX2013014097A MX2013014097A MX358040B MX 358040 B MX358040 B MX 358040B MX 2013014097 A MX2013014097 A MX 2013014097A MX 2013014097 A MX2013014097 A MX 2013014097A MX 358040 B MX358040 B MX 358040B
Authority
MX
Mexico
Prior art keywords
calcium
organism
bone cavity
cavity formations
filling bone
Prior art date
Application number
MX2013014097A
Other languages
English (en)
Other versions
MX2013014097A (es
Inventor
Ivanovich Strukov Villorij
Nikolaevich Trifonov Vjacheslav
Anatol'evna Elistratova Julija
Gennad'evich Elistratov Konstantin
Vjacheslavovna Kurus Natal'ja
Original Assignee
Obshchestvo S Ogranichennoj Otvetstvennostju Parafarm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obshchestvo S Ogranichennoj Otvetstvennostju Parafarm filed Critical Obshchestvo S Ogranichennoj Otvetstvennostju Parafarm
Publication of MX2013014097A publication Critical patent/MX2013014097A/es
Publication of MX358040B publication Critical patent/MX358040B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Insects & Arthropods (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una combinación de cría de zánganos y calcio, para usarse en el tratamiento de cavidades en secciones metafiseanas (trabeculares) del hueso, mediante el rellenado con calcio, y prevención de la secreción de calcio de los huesos.
MX2013014097A 2011-05-31 2012-01-31 Combinación de cría de zánganos y calcio para usarse en el tratamiento de cavidades en secciones metafiseanas (trabeculares). MX358040B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2011121932/15A RU2466732C1 (ru) 2011-05-31 2011-05-31 Способ заполнения полостных образований в метафизарных (трабекулярных) участках костей кальцием и предотвращения выведения из них кальция
PCT/RU2012/000049 WO2012166003A1 (ru) 2011-05-31 2012-01-31 Способ заполнения кальцием полостных образований костей

Publications (2)

Publication Number Publication Date
MX2013014097A MX2013014097A (es) 2014-07-14
MX358040B true MX358040B (es) 2018-08-02

Family

ID=47259596

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014097A MX358040B (es) 2011-05-31 2012-01-31 Combinación de cría de zánganos y calcio para usarse en el tratamiento de cavidades en secciones metafiseanas (trabeculares).

Country Status (20)

Country Link
US (1) US20140106000A1 (es)
EP (1) EP2740481B1 (es)
JP (3) JP5917687B2 (es)
CN (3) CN103153319A (es)
AU (2) AU2012263018A1 (es)
CA (1) CA2837697C (es)
DK (1) DK2740481T3 (es)
EA (1) EA024641B1 (es)
ES (1) ES2690219T3 (es)
IL (2) IL229551A (es)
IN (1) IN2013MN02450A (es)
LT (1) LT2740481T (es)
MX (1) MX358040B (es)
PL (1) PL2740481T3 (es)
PT (1) PT2740481T (es)
RS (1) RS57782B1 (es)
RU (1) RU2466732C1 (es)
SI (1) SI2740481T1 (es)
UA (1) UA107638C2 (es)
WO (1) WO2012166003A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2549461C2 (ru) * 2013-01-11 2015-04-27 Общество С Ограниченной Ответственностью "Парафарм" Способ и препарат для лечения артритов и артрозов
RU2564111C9 (ru) * 2013-07-03 2016-03-20 Общество С Ограниченной Ответственностью "Парафарм" Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа
RU2664838C1 (ru) * 2017-11-07 2018-08-23 Наиля Зиафутдиновна Хисматуллина Добавка пищевая комплексная и способ её применения

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO74872A2 (ro) * 1980-01-21 1983-11-01 Cooperativa Agricola De Productie,Ro Procedeu pentru obtinerea unui produs apicol biologic activ
US4772467A (en) * 1985-02-19 1988-09-20 Board Of Regents, U T Systems Osteoporosis inhibition by dietary calcium supplementation
CN1028200C (zh) * 1988-09-07 1995-04-19 刘本华 雄蜂营养素的提取方法
CN1045276A (zh) * 1989-03-02 1990-09-12 刘本华 雄蜂营养成分的提取工艺及其用途
US5731299A (en) * 1992-05-29 1998-03-24 The Procter & Gamble Company Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
RO119924B1 (ro) * 2000-02-22 2005-06-30 Ionuţ Moraru Produs medicamentos natural, pentru tratamentul osteoporozei
RU2233666C1 (ru) * 2002-12-30 2004-08-10 Пятигорская государственная фармацевтическая академия Таблетки "апилар" на основе трутневого расплода, обладающие анаболическим, актопротекторным действием
KR20050040660A (ko) * 2003-10-29 2005-05-03 박인희 해조칼슘 깨벌꿀의 제조방법
CN1954695A (zh) * 2005-10-27 2007-05-02 天津中英纳米科技发展有限公司 雄蜂制品及其生产方法
RU2338551C1 (ru) * 2007-08-31 2008-11-20 Римма Галиевна Сайфутдинова Средство для профилактики остеопороза
RU2412616C1 (ru) * 2009-11-30 2011-02-27 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики заболеваний остеопорозом

Also Published As

Publication number Publication date
EP2740481A1 (en) 2014-06-11
CA2837697C (en) 2019-11-26
IN2013MN02450A (es) 2015-06-12
EA024641B1 (ru) 2016-10-31
AU2012263018A1 (en) 2014-01-16
AU2017203767A1 (en) 2017-07-06
EP2740481A4 (en) 2014-12-24
AU2017203767B2 (en) 2019-01-03
UA107638C2 (uk) 2015-01-26
JP2018135398A (ja) 2018-08-30
PT2740481T (pt) 2018-11-05
JP2016047856A (ja) 2016-04-07
RU2466732C1 (ru) 2012-11-20
JP5917687B2 (ja) 2016-05-18
DK2740481T3 (en) 2018-10-15
US20140106000A1 (en) 2014-04-17
ES2690219T3 (es) 2018-11-19
CA2837697A1 (en) 2012-12-06
EA201301348A1 (ru) 2014-07-30
CN107252437A (zh) 2017-10-17
SI2740481T1 (sl) 2018-11-30
IL253198A (en) 2018-06-28
EP2740481B1 (en) 2018-07-11
RS57782B1 (sr) 2018-12-31
IL229551A (en) 2017-10-31
IL229551A0 (en) 2014-01-30
PL2740481T3 (pl) 2019-02-28
CN103153319A (zh) 2013-06-12
CN107252436A (zh) 2017-10-17
MX2013014097A (es) 2014-07-14
WO2012166003A1 (ru) 2012-12-06
LT2740481T (lt) 2018-11-12
JP2014515398A (ja) 2014-06-30
NZ619215A (en) 2016-01-29
JP6404244B2 (ja) 2018-10-10

Similar Documents

Publication Publication Date Title
HRP20180957T1 (hr) Metoda za pripremu adipoznog tkiva za transplantaciju od lobularne masti koja je izvučena liposukcijom
EP3473726B8 (en) Fermentation technique to improve production level of recombinant human collagen
MX353111B (es) Control remoto de una mecanica de juego de primer usuario por un segundo usuario.
SG10201910753RA (en) A method to direct differentiation of pluripotent stem cells into functional heart muscle
EP2967920A4 (en) ANKLE PROSTHESIS AND APPROPRIATE CONTROL METHOD, BASED ON ADAPTATION TO SPEED
PH12014501453B1 (en) Method of reducing exercise-induced joint pain in non-arthritic mammals
IL231746A0 (en) Apparatus and method for implant control
HK1198625A1 (en) Implants and methods of using the implants to fill holes in bone tissue
HK1219239A1 (zh) 植入物和通過負壓下使組織去細胞化來製造植入物的方法
PH12017501393A1 (en) Methods and compositions for decreasing gastric emptying
EP2692858A4 (en) METHOD FOR MANUFACTURING ARTIFICIAL SKIN MODEL, AND ARTIFICIAL SKIN MODEL
MX2017007635A (es) Metodos de produccion de polipeptidos de hormona de crecimiento modificada por ctp de accion prolongada.
IL232107B (en) Methods for stimulating the growth of stem cells or progenitor cells, for inducing the return of cells to a lower degree of maturity and for creating stem cell populations
PH12016500819A1 (en) Methods for reducing matrix-bound nicotine-derived nitrosamine ketone in tobacco plant material
MX2016016353A (es) Sistema y metodo para anclaje de valvula cardiaca.
WO2012097272A8 (en) Stable hydrogel compositions including additives
EP2741788A4 (en) METHOD AND COMPOSITION FOR IN-SITU FORMATION OF AN ARTIFICIAL BARRIER FOR FIGHTING BLOOD LOSS
IN2013MN02450A (es)
IL235169B (en) A method for the prevention and treatment of atypical osteoporosis that includes normal or increased mineralization of bone tissue with cavities in the trabecular bone (as well as in similar conditions involving excess mass and metabolic syndrome)
EP2571337A4 (en) METHOD FOR PRODUCING A SUPER PLAIN ACCELERATION ROOM
PH12015501173A1 (en) Water delivery system
WO2014109678A8 (ru) Способ и препарат для лечения артритов и артрозов
UA65158U (ru) Способ лечения трофических язв нижних конечностей
UA72343U (ru) Способ лечения хронического верхушечного периодонтита
UA75480U (uk) Спосіб оптимізації остеокондуктивних властивостей кісткової тканини

Legal Events

Date Code Title Description
FG Grant or registration